Anti-Spike-RBD mAb
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment[1].
Product Specifications
CAS Number
[9007-83-4]
Product Name Alternative
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/anti-spike-rbd-mab.html
Purity
95.0
Solubility
H2O
Smiles
[Anti-Spike-RBDmAb]
References & Citations
[1]Chunyan Wang, et al. A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection. Nat Commun. 2020 May 4;11 (1) :2251.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
035800-Biotin 200 µL
FUT4, CT (FUT4, ELFT, FCT3A, Alpha- (1,3) -fucosyltransferase, ELAM-1 ligand fucosyltransferase, Fucosyltransferase 4, Fucosyltransferase IV, Galactoside 3-L-fucosyltransferase) (Biotin) discontinued
Ask
View Details 
